Rezolute (RZLT) Competitors $8.93 +0.12 (+1.31%) As of 10:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RZLT vs. TLX, INDV, NAMS, CNTA, AMRX, QURE, XENE, VKTX, CGON, and MORShould you be buying Rezolute stock or one of its competitors? The main competitors of Rezolute include Telix Pharmaceuticals (TLX), Indivior (INDV), NewAmsterdam Pharma (NAMS), Centessa Pharmaceuticals (CNTA), AMNEAL PHARMACEUTICALS (AMRX), uniQure (QURE), Xenon Pharmaceuticals (XENE), Viking Therapeutics (VKTX), CG Oncology (CGON), and MorphoSys (MOR). These companies are all part of the "pharmaceutical products" industry. Rezolute vs. Its Competitors Telix Pharmaceuticals Indivior NewAmsterdam Pharma Centessa Pharmaceuticals AMNEAL PHARMACEUTICALS uniQure Xenon Pharmaceuticals Viking Therapeutics CG Oncology MorphoSys Telix Pharmaceuticals (NASDAQ:TLX) and Rezolute (NASDAQ:RZLT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends. Which has preferable earnings and valuation, TLX or RZLT? Telix Pharmaceuticals has higher revenue and earnings than Rezolute. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelix Pharmaceuticals$516.72M6.59$32.93MN/AN/ARezoluteN/AN/A-$74.41M-$0.97-9.20 Does the media refer more to TLX or RZLT? In the previous week, Telix Pharmaceuticals had 2 more articles in the media than Rezolute. MarketBeat recorded 6 mentions for Telix Pharmaceuticals and 4 mentions for Rezolute. Telix Pharmaceuticals' average media sentiment score of 0.57 beat Rezolute's score of -0.08 indicating that Telix Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Telix Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rezolute 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend TLX or RZLT? Telix Pharmaceuticals presently has a consensus price target of $21.00, suggesting a potential upside of 108.64%. Rezolute has a consensus price target of $14.50, suggesting a potential upside of 62.46%. Given Telix Pharmaceuticals' higher probable upside, analysts plainly believe Telix Pharmaceuticals is more favorable than Rezolute.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Telix Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57Rezolute 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.88 Is TLX or RZLT more profitable? Telix Pharmaceuticals' return on equity of 0.00% beat Rezolute's return on equity.Company Net Margins Return on Equity Return on Assets Telix PharmaceuticalsN/A N/A N/A Rezolute N/A -65.03%-58.86% Do insiders & institutionals hold more shares of TLX or RZLT? 83.0% of Rezolute shares are held by institutional investors. 18.4% of Rezolute shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryTelix Pharmaceuticals beats Rezolute on 7 of the 12 factors compared between the two stocks. Get Rezolute News Delivered to You Automatically Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RZLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RZLT vs. The Competition Export to ExcelMetricRezoluteMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$802.13M$3.34B$6.13B$10.63BDividend YieldN/A2.29%5.51%4.67%P/E Ratio-9.1122.0086.0727.10Price / SalesN/A409.13587.32183.34Price / CashN/A46.3226.3031.10Price / Book4.809.9813.096.71Net Income-$74.41M-$52.42M$3.30B$276.23M7 Day Performance-5.05%6.49%5.49%4.30%1 Month Performance11.56%12.83%9.27%11.61%1 Year Performance86.72%26.45%86.14%41.42% Rezolute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RZLTRezolute2.6423 of 5 stars$8.93+1.3%$14.50+62.5%+78.7%$802.13MN/A-9.1140TLXTelix Pharmaceuticals4.3516 of 5 stars$9.89-0.9%$21.00+112.3%N/A$3.38B$516.72M0.00N/AShort Interest ↓Gap DownINDVIndivior3.1237 of 5 stars$24.10+0.8%$22.00-8.7%+118.1%$3.30B$1.17B38.871,051NAMSNewAmsterdam Pharma2.979 of 5 stars$27.52-3.4%$42.00+52.6%+78.3%$3.21B$64.01M-16.994CNTACentessa Pharmaceuticals3.3574 of 5 stars$24.40+4.9%$32.38+32.7%+44.3%$3.11B$6.85M-13.63200Analyst ForecastAMRXAMNEAL PHARMACEUTICALS2.7468 of 5 stars$9.87+1.2%$12.00+21.6%+22.0%$3.06B$2.79B987.998,100QUREuniQure3.6686 of 5 stars$59.40+9.4%$67.17+13.1%+836.5%$2.98B$27.12M-15.15500Analyst ForecastAnalyst RevisionXENEXenon Pharmaceuticals2.7695 of 5 stars$39.06+2.8%$53.30+36.5%-2.9%$2.93B$9.43M-11.00210Positive NewsAnalyst ForecastVKTXViking Therapeutics4.0533 of 5 stars$25.81+0.9%$86.42+234.8%-50.3%$2.88BN/A-16.8720CGONCG Oncology2.3574 of 5 stars$39.08+4.1%$56.55+44.7%+4.1%$2.86B$1.14M-22.0861MORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730News Coverage Related Companies and Tools Related Companies TLX Alternatives INDV Alternatives NAMS Alternatives CNTA Alternatives AMRX Alternatives QURE Alternatives XENE Alternatives VKTX Alternatives CGON Alternatives MOR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RZLT) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rezolute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rezolute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
